EXPRESION ESPECIFICA DE TEJIDO DE LA PROTEINA DEL RETINOBLASTOMA

LA INVENCION SE REFIERE A FUSIONES DEL FACTOR DE TRANSCRIPCION E2F Y DE LA PROTEINA DEL RETINOBLASTOMA (RB), JUNTO CON PROCEDIMIENTOS DE TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS. Fusions of the transcription factor E2F and the retinoblastoma protein RB are provided, along with methods of trea...

Full description

Saved in:
Bibliographic Details
Main Authors ANTELMAN, DOUGLAS, GREGORY, RICHARD, J, WILLS, KENNETH, N
Format Patent
LanguageSpanish
Published 16.06.2005
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:LA INVENCION SE REFIERE A FUSIONES DEL FACTOR DE TRANSCRIPCION E2F Y DE LA PROTEINA DEL RETINOBLASTOMA (RB), JUNTO CON PROCEDIMIENTOS DE TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS. Fusions of the transcription factor E2F and the retinoblastoma protein RB are provided, along with methods of treatment of hyperproliferative diseases.
Bibliography:Application Number: ES19970952238T